Blog

IDA recently completed its first Double Materiality Assessment (DMA), in line with the EU Corporate Sustainability Reporting Directive (CSRD) and European Sustainability Reporting Standards (ESRS).

Sub-standard and even falsified medicines are a well-known risk in international pharmaceutical supply chains. A recent Lancet article has brought attention on concerning results of in-market testing for available chemotherapy products in low- and middle-income countries (LMICs).

IDA Foundation is proud to announce that we have been awarded a Silver Medal in our second assessment by EcoVadis, a globally recognised sustainability ratings platform. This marks a significant milestone in our sustainability journey: after receiving a Bronze Medal last year, we set a clear goal to improve our performance - and we are thrilled to have achieved it!

Making biofuels a more viable and standard choice by secured agreements with main freight forwarders to prioritise alternative fuel options.

Strengthen local health systems and support local partners through knowledge sharing and capacity building.

IDA is leading a pivotal plenary session on "Disparities in Cancer Care"

The IDA Foundation 2023 Sustainability Report is online, confirming our continuing commitment to the UN Global Compact 10 principles related to Human Rights, Labour, Environment and Anti-Corruption.

IDA Foundation is proud to announce that we have been awarded with a Bronze Medal in its first assessment of EcoVadis, an internationally recognised sustainability ratings provider. Even though this was IDA Foundation’s first assessment, our overall score of 63/100 points puts IDA in the 81st percentile of all companies assessed by EcoVadis and also places it among the best-ranking companies in its industry segment (Wholesale).

IDA Foundation and ATOM Coalition Join Forces to Bridge Gaps in Cancer Treatment Access through NCDconnect. IDA Foundation and the Access to Oncology Medicines (ATOM) Coalition are happy to announce their strategic partnership. Following World Cancer Day’s theme ‘Close the Care Gap’, this collaboration marks a significant step toward addressing the challenges of availability, affordability, and appropriate use of oncology medicines in low- and middle-income countries (LMICs).